Acute Hyperkalemia clinical trials at UC Irvine
1 research study open to eligible people
open to eligible people ages 18 years and up
Compare efficacy of 3 oral potassium binders (cation exchange resins) on lowering blood potassium, in hospital patients with acute hyperkalemia.
Our lead scientists for Acute Hyperkalemia research studies include Wei Ling Lau.